Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Biodesix (BDSX) Return on Sales: 2020-2025

Historic Return on Sales for Biodesix (BDSX) over the last 6 years, with Sep 2025 value amounting to -0.50%.

  • Biodesix's Return on Sales rose 17.00% to -0.50% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.50%, marking a year-over-year increase of 17.00%. This contributed to the annual value of -0.60% for FY2024, which is 44.00% up from last year.
  • Latest data reveals that Biodesix reported Return on Sales of -0.50% as of Q3 2025, which was up 7.98% from -0.54% recorded in Q2 2025.
  • Over the past 5 years, Biodesix's Return on Sales peaked at -0.39% during Q1 2021, and registered a low of -1.80% during Q2 2022.
  • In the last 3 years, Biodesix's Return on Sales had a median value of -0.70% in 2024 and averaged -0.89%.
  • In the last 5 years, Biodesix's Return on Sales surged by 112bps in 2021 and then plummeted by 142bps in 2022.
  • Biodesix's Return on Sales (Quarterly) stood at -0.83% in 2021, then slumped by 70bps to -1.54% in 2022, then skyrocketed by 50bps to -1.04% in 2023, then spiked by 44bps to -0.60% in 2024, then rose by 17bps to -0.50% in 2025.
  • Its last three reported values are -0.50% in Q3 2025, -0.54% for Q2 2025, and -0.54% during Q1 2025.